COVID-19 vaccines are in high demand, and there aren’t enough of them. Some countries have yet to receive a single dose. In Canada, a company is testing out an unusual approach to expand the supply to places with less access. It wants to make a vaccine on its own, one that it didn’t develop. As The World’s Elana Gordon reports, this unusual move is adding to a fierce global debate about who controls vaccine knowledge and production in a pandemic.
We want to hear your feedback so we can keep improving our website, theworld.org. Please fill out this quick survey and let us know your thoughts (your answers will be anonymous). Thanks for your time!